| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 347.02B | 375.89B | 379.30B | 373.76B | 362.59B |
| Gross Profit | 160.82B | 212.78B | 205.15B | 210.80B | 204.32B |
| EBITDA | 87.30B | 85.97B | 79.78B | 77.56B | 69.00B |
| Net Income | 68.79B | 68.58B | 67.02B | 62.10B | 55.64B |
Balance Sheet | |||||
| Total Assets | 10.14T | 9.53T | 9.05T | 8.55T | 8.04T |
| Cash, Cash Equivalents and Short-Term Investments | 556.63B | 887.49B | 746.93B | 780.36B | 696.80B |
| Total Debt | 3.07T | 260.20B | 1.06T | 1.06T | 1.05T |
| Total Liabilities | 9.36T | 8.73T | 8.32T | 7.86T | 7.40T |
| Stockholders Equity | 759.14B | 789.26B | 717.22B | 665.42B | 626.30B |
Cash Flow | |||||
| Free Cash Flow | 67.55B | -199.81B | -14.44B | 188.27B | -79.88B |
| Operating Cash Flow | 104.39B | -181.03B | -918.00M | 195.07B | -75.39B |
| Investing Cash Flow | -527.64B | -29.53B | 1.89B | -115.87B | -206.79B |
| Financing Cash Flow | 496.51B | 220.80B | -63.10B | -32.54B | 219.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.15T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
71 Outperform | HK$456.53B | 10.39 | 11.77% | 5.80% | 1.90% | 12.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$504.37B | 5.02 | 9.01% | 5.76% | -5.46% | 0.33% | |
57 Neutral | HK$206.87B | 5.64 | 6.61% | 5.53% | -8.41% | -5.52% | |
57 Neutral | HK$649.92B | 6.72 | 9.30% | 5.37% | -1.54% | -3.95% | |
52 Neutral | HK$179.94B | 5.60 | 4.68% | 9.09% | -7.28% | -5.00% |